Discover the Science of Health
Last week Thursday, an FDA advisory panel recommended the approval of Novo Nordisk’s injectable drug liraglutide for the treatment of obesity.
Sign up to receive email updates!
Disclaimer | Advertising Policy | Advertise with Highlight HEALTH
Copyright © 2017 Highlight Health Media
Return to top of page